Effects of Foot Rehabilitation And Minimalist Shoes on Pain, Strength, and Function in Adults With Plantar Fasciopathy (FRAMES)

October 24, 2023 updated by: Jen Xu, University of Virginia

The Effects of Foot Rehabilitation And Minimalist Shoes (FRAMES) on Pain, Strength, and Function in Adults With Plantar Fasciopathy

The goal of this clinical trial is to compare the effects of 8 weeks of foot rehabilitation exercises in conjunction with wearing minimalist shoes in individuals with plantar fasciopathy, compared to only performing foot rehabilitation exercises. The main questions it aims to answer are:

  • Will individuals with plantar fasciopathy be able to reduce their pain and improve their self-reported function by performing rehabilitation exercises and wearing minimalist shoes, compared to those only performing rehabilitation exercises?
  • Will individuals with plantar fasciopathy be able to increase their intrinsic foot muscle strength and size, their balance, and gait biomechanics by performing rehabilitation exercises and wearing minimalist shoes, compared to those only performing rehabilitation exercises?
  • What characteristics of individuals with plantar fasciopathy make them most suited to succeed in a protocol of performing rehabilitation exercises and wearing minimalist shoes?

Participants will be asked to come into the lab at the start of the intervention and after 8 weeks, where the following will be assessed:

  • Patient-reported outcomes
  • Foot morphology
  • Intrinsic foot muscle strength
  • Balance
  • Gait biomechanics

For the intervention, participants in both groups will perform the same rehabilitation exercises, including:

  • Massage to the bottom of the foot
  • Calf-raises
  • Calf and foot stretches

Study Overview

Detailed Description

The purpose of the study is to determine the effects of 8-weeks of wearing minimalist shoes and performing a home exercise program (intervention group) on pain, self-reported function, intrinsic foot muscle strength and size, balance, and gait biomechanics, as opposed to receiving a home exercise program alone (control group).

All participants will report to the Exercise and Sport Injury Laboratory for a baseline clinical assessment performed by a blinded assessor to determine their level of pain and their self-reported function using a variety of patient-reported outcomes. These include pain levels on a Visual Analog Scale (VAS), Global Rating of Change to assess perceived changes in function, Foot Health Status Questionnaire (FHSQ) to gather general and foot-related health information, and a variety of scales that assess kinesiophobia, fear-avoidance belief, self-efficacy, and activity level. Functional measures include intrinsic foot muscle strength via diagnostic ultrasound, intrinsic foot muscle size via two different types of handheld dynamometer, balance via a single-leg balancing task on a force plate, and gait biomechanics via a walking task with insoles that can obtain measures of force and loading rate.

At the end of the first baseline visit, all participants will be taught how to perform the home rehabilitation exercise routine, and handed an informational sheet that will have pictures and links to supplemental videos to ensure that they understand the exercises and have the resources to review.

Immediately following the first baseline visit, participants will meet with another member of the study team to ensure assessor blinding. They will be randomly assigned to one of two groups: the intervention group of foot rehabilitation and minimalist shoes (intervention), or the control group of just rehabilitation exercises (control). The randomization sequence will be created a priori with a random-number generator stratified by sex, placed in sealed opaque envelopes by another member of the study team to blind the assessor. Participants in the intervention group will have a pair of shoes ordered for them, and they will begin the protocol when the shoes have arrived.

Participants in both groups will be instructed to fill out a daily survey that will be sent via text and stored in a secure server (REDCap), that will indicate if they have completed their rehabilitation exercises. Participants will also all wear Fitbit smart watches that will track their step count and some other health-related metrics. They will not be able to see their own data during the protocol.

At the 4-week mark of the study, all individuals will be sent a link to take surveys of patient-reported outcomes, including pain levels, self-reported function, kinesiophobia, fear-avoidance belief, self-efficacy, and activity level. They will also complete a phone call with a member of the study team (not the assessor, to maintain blinding) as a check-in to discuss pain levels and any other questions and concerns they have.

At the end of the 8-weeks, individuals will return to the lab to have the same measures as the baseline session completed. The investigators will then be able to determine if performing foot rehabilitation exercises and wearing minimalist shoes reduces pain, improves self-reported function, and increases intrinsic foot muscle strength and size, balance, and gait biomechanics, compared to baseline and to the control group.

Study Type

Interventional

Enrollment (Estimated)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Virginia
      • Charlottesville, Virginia, United States, 22903
        • University of Virginia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Between ages of 18 - 55 years old
  • First-step pain in the morning over past week - Visual Analog Score between 30-70 mm
  • Heel pain for at least a month with an insidious onset

Exclusion Criteria:

  • Other current lower extremity neuromusculoskeletal injury
  • Other lower extremity neuromusculoskeletal injuries other than the foot in the past 3 months
  • Previous history of foot/ankle fractures or surgeries
  • Current participation in formal rehab for plantar fasciopathy
  • Previous minimalist shoe experience

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Foot Rehabilitation And Minimalist Shoes (FRAMES)
The intervention group will receive a pair of minimalist shoes along with a home exercise program and a protocol that indicates how to slowly adjust to wearing the shoes.

Participants will receive a home exercise program that consists of 2 exercises and 3 stretches. The exercises include:

  • Massage on the bottom of the foot with a ball
  • Calf-raises
  • Lunge calf-stretch with the knee straight
  • Calf-stretch with the knee bent
  • Stretch for the bottom of the foot

These exercises are intended to be performed daily.

Participants will receive a pair of minimalist shoes. They will wear them for an allotted amount of time per day each week, in order to allow for a slow adjustment into the shoes. The protocol is as follows:

  • Week 1: 1 hour per day
  • Week 2: 2 hours per day
  • Week 3: 4 hours per day
  • Week 4: 6 hours per day
  • Week 5: 8 hours per day
  • Week 6: 8 hours per day
  • Week 7: 8 hours per day
  • Week 8: 8 hours per day
Active Comparator: Home Exercise Program (Control)
The intervention group will receive a home exercise program.

Participants will receive a home exercise program that consists of 2 exercises and 3 stretches. The exercises include:

  • Massage on the bottom of the foot with a ball
  • Calf-raises
  • Lunge calf-stretch with the knee straight
  • Calf-stretch with the knee bent
  • Stretch for the bottom of the foot

These exercises are intended to be performed daily.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Pain
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.

Visual Analog Scale (0-100 mm) pain outcome scores for the following items:

  • Average pain over the past week
  • First-step pain over the past week (the pain that is felt upon waking up in the morning and taking a first step)
  • Average heel pain of the day
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in perception of overall recovery
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Global Rating of Change (GROC) outcome scores
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in self-reported function and health
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Foot Health Status Questionnaire (FHSQ) outcome scores
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in foot morphology: length, width, arch height, and girth
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Arch Height Index tool outcome measures
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in intrinsic foot muscle size
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Muscle thickness and cross-sectional area of the abductor hallucis, flexor hallucis brevis, flexor digitorum brevis, and quadratus plantae, using diagnostic ultrasound in a weight-bearing position.
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in intrinsic foot muscle strength
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Tested separately for the great toe and lesser toes using two different types of handheld dynamometer
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in center of pressure (COP) distance during balance
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
COP distance using a force plate during a single-limb balance task, eyes open and eyes closed.
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in foot posture outcomes
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Clinical foot posture index assessment (23-point scale)
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in center of pressure (COP) velocity during balance
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
COP velocity using a force plate during a single-limb balance task, eyes open and eyes closed.
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in center of pressure (COP) 95% ellipse area during balance
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
COP 95% ellipse area using a force plate during a single-limb balance task, eyes open and eyes closed.
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in vertical ground reaction force (vGRF) of the rearfoot
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
The force (N) during treadmill and overground walking using loadsol sensors
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in kinesiophobia
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Tampa Scale of Kinesiophobia (TSK-11) outcome scores
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in fear-avoidance belief
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Fear-Avoidance Belief Questionnaire (FABQ) outcome scores
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in pain self-efficacy
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Pain Self-Efficacy Questionnaire (PSEQ) outcome scores
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in activity level
Time Frame: This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
National Aeronautics and Space Administration Activity Survey (NAS)
This outcome change will be measured from baseline, to the midpoint of the intervention (4 weeks), to the end of the intervention (8 weeks) for both groups.
Change in vertical ground reaction force (vGRF) of the whole foot
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
The force (N) during treadmill and overground walking using loadsol sensors
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in vertical ground reaction force (vGRF) of the midfoot
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
The force (N) during treadmill and overground walking using loadsol sensors
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in vertical ground reaction force (vGRF) of the forefoot
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
The force (N) during treadmill and overground walking using loadsol sensors
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in average loading rate
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
The loading rate (N/s) during treadmill and overground walking using loadsol sensors
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in instantaneous loading rate
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
The loading rate (N/s) during treadmill and overground walking using loadsol sensors
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in knee sagittal plane kinematics
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Knee sagittal plane joint moment (in Nm/kg) measured during the overground gait analysis using markerless motion capture
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in hip sagittal plane kinematics
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Hip sagittal plane joint moment (in Nm/kg) measured during the overground gait analysis using markerless motion capture
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in ankle sagittal plane kinematics
Time Frame: This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Ankle sagittal plane joint moment (in Nm/kg) measured during the overground gait analysis using markerless motion capture
This outcome change will be measured from baseline, to the end of the intervention (8 weeks) for both groups.
Change in steps per day
Time Frame: This outcome change will be measured everyday for 8 weeks
Steps per day measured on a Fitbit
This outcome change will be measured everyday for 8 weeks
Change in activity level per day
Time Frame: This outcome change will be measured everyday for 8 weeks
Hours of activity per day measured on a Fitbit
This outcome change will be measured everyday for 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer Xu, MS, University of Virginia
  • Principal Investigator: Susan Saliba, PhD, University of Virginia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 20, 2023

Primary Completion (Estimated)

April 20, 2025

Study Completion (Estimated)

May 20, 2025

Study Registration Dates

First Submitted

October 19, 2023

First Submitted That Met QC Criteria

October 24, 2023

First Posted (Actual)

October 30, 2023

Study Record Updates

Last Update Posted (Actual)

October 30, 2023

Last Update Submitted That Met QC Criteria

October 24, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • HSR230045

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Plantar Fascitis

Clinical Trials on Home Exercise Program

3
Subscribe